DNV Secures Notified Body Status for In Vitro Diagnostic Devices
DNV Recognized as Notified Body Under IVDR
DNV, an independent assurance and risk management provider, has received recognition from the European Commission as a notified body for the certification of devices under the European Union's In Vitro Diagnostic Regulation (IVDR). This vital designation aims to boost the capacity for certifying in vitro diagnostic devices, which is essential for gaining entry to the EU market.
Understanding In Vitro Diagnostics
In vitro diagnostics (IVDs) encompass a wide range of tests that help determine an individual's health status. These tests include everything from pregnancy tests, cholesterol checks, to crucial screenings for HIV, COVID-19, and cancer markers. Given the direct impact of these devices on public and personal health, ensuring their safety and effectiveness is of utmost importance.
The Importance of IVDR Regulation
The IVDR, which was introduced in 2017, supersedes the previous In Vitro Diagnostic Directive 98/79/EC (IVDD). This new regulation establishes a comprehensive framework for assessing the safety and effectiveness of new in vitro diagnostic devices. Most IVD devices will require a certificate of compliance with the IVDR before they can be marketed in the EU. The classification of these devices is based on their risk levels concerning public health. Notably, Class D devices, which pose the highest risks, must obtain IVDR certification by May 2025, while Class C and Class B devices have deadlines in May 2026 and May 2027 respectively.
Enhancing Certification Capacity
With DNV's designation as an IVDR notified body, the certification landscape gains increased capacity, thereby assisting more manufacturers in accessing the EU market. This change is particularly significant in a sector where regulatory compliance is critical for device manufacturers aiming to enter new markets.
A Digital Approach to Certification
To enhance efficiency in the certification process, DNV provides a fully digital certification pathway. This innovative approach enables manufacturers to handle certification documents online and monitor their compliance status in real time. Such a secure digital platform not only expedites certification but also introduces a higher level of transparency throughout the process.
Expertise and Commitment to Manufacturers
“DNV is eager to collaborate with manufacturers across all classes of IVD devices, assisting them in effectively accessing the EU market,” stated Cecilie Gudesen Torp, Global Director of Medical Services, Supply Chain & Product Assurance at DNV. “As one of the top five notified bodies for medical device certification, we bring a wealth of expertise and technical competence. Our international team of auditors, technical assessors, and clinicians is well-equipped to provide efficient certification services with the utmost reliability, thereby lowering risks and accelerating manufacturers' market entry.”
Frequently Asked Questions
What does it mean to be a Notified Body under IVDR?
A Notified Body, like DNV, is designated to ensure that in vitro diagnostic devices meet necessary safety and effectiveness criteria before they can be marketed in the EU.
Why is IVDR important for medical devices?
The IVDR sets a high standard for quality and safety in in vitro diagnostics, protecting public health by ensuring only compliant devices enter the market.
How does DNV's digital certification process work?
DNV offers a fully digital certification system that allows manufacturers to manage documents online and track compliance status efficiently.
What types of devices require IVDR certification?
Most in vitro diagnostic devices, including pregnancy tests and disease screening tests, will require IVDR certification to be sold in the EU.
How can manufacturers prepare for IVDR compliance?
Manufacturers should familiarize themselves with the IVDR regulations, ensure their products meet the criteria, and utilize resources like DNV’s certification guides.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
